The ubiquitin-proteasome pathway plays a crucial role in many cellular processes by degrading substrates tagged by polyubiquitin chains, linked mostly through lysine 48 of ubiquitin. Although polymerization of ubiquitin via its six other lysine residues exists in vivo as part of various physiological pathways, the molecular mechanisms that determine the type of polyubiquitin chains remained largely unknown. We undertook a systematic, in vitro, approach to evaluate the role of E2 enzymes in determining the topology of polyubiquitin. Because this study was performed in the absence of an E3 enzyme, our data indicate that the E2 enzymes are capable of directing the ubiquitination process to distinct subsets of ubiquitin lysines, depending on the specific E2 utilized. Moreover, our findings are in complete agreement with prior analyses of lysine preference assigned to certain E2s in the context of E3 (in vitro and in vivo). Finally, our findings support the raising notion that the E2s functional unit is a dimer. To our knowledge this is the first systematic indication for the involvement of E2 enzymes in specifying polyubiquitin chain assembly.
In eukaryotic cells most proteins are degraded by the 26S proteasome, which hydrolyzes in an ATP dependant manner, both ubiquitin-conjugated and certain non-ubiquitinated proteins. In addition to its role in the turnover of damaged or misfolded proteins, the proteasome controls the cell cycle and other processes through the degradation of critical regulatory components and transcription factors (1) (2) (3) . Upon association of ubiquitinated targets with the proteasome, ubiquitin molecules are proteolytically removed for re-use, while the unfolded substrates are fed into the 20S catalytic core where they are digested into small peptides (4, 5) . Protein ubiquitination is a multi-step process orchestrated by the concerted action of three enzymes. The chain reaction begins with a ubiquitin-activating enzyme (E1), which initially adenylates the C-terminal glycine of ubiquitin. Next, a thioester bond is formed between the activated C-terminus of ubiquitin and a cysteine residue of the E1. A ubiquitin conjugating enzyme (E2) acquires the activated ubiquitin through a trans-thioesterification reaction. Finally, a RING ubiquitin-protein ligase (E3) recruits the substrate and guides the transfer of the ubiquitin from the E2 active site cysteine to the substrate. An ε amine of a lysine residue on the substrate (or of additional ubiquitin) attacks the thioester bond between the ubiquitin and the E2 enzyme forming an isopeptide bond with the C-terminal glycine of the ubiquitin (6) (7) (8) . Alternatively, when a HECT E3 catalyzes the transfer of the ubiquitin from the E2 to the target, an intermediate complex, of the activated ubiquitin and the active site cysteine of the HECT domain E3, is formed (9) . Several forms of ubiquitination have been identified (10) . Single or multiple monoubiquitinations have been described where a single or multiple ubiquitin moieties are conjugated to distinct lysine residues on the substrates, but they do not polymerize. These forms of ubiquitination were implicated in diverse cellular pathways, which include endocytosis and sorting of proteins to different cellular compartments (11, 12 ). Yet, recently it was also shown to participate in several cases of proteasomal activity, such as the processing of the p105 precursor of the NF-B transcriptional regulator (13) . However, polyubiquitination, which is the covalent assembly of a chain of ubiquitin molecules on one or multiple lysine residues of the substrate, is the most common form of post-translational modification of proteins destined for degradation (14) . Traditionally, polyubiquitin elongation was thought to proceed as a sequential reaction by the addition of ubiquitin molecules, one at a time, in a cyclic manner. First to a lysine residue on the target protein and from then on to a lysine residue on the distal end of the growing ubiquitin chain.
However, in view of recent findings, several alternative mechanisms have been proposed (see (15) for review). Li et al. demonstrated , in vitro, a mode of action in which polyubiquitin is initially assembled on the active site cysteine of an E2 (E2G2), presumably by the action of additional E2 molecules (16) . Once polyubiquitin is constructed, a RING E3 enzyme (gp78) catalyzes the transfer of the polyubiquitin, as a module, to a lysine residue of the target substrate (the C-terminus of HERP, a known substrate of these E2/E3 enzymes). However, it is unclear whether en block transfer of polyubiquitin also occurs in vivo. In a related study, Ravid and Hochstrasser proposed that the active site polyubiquitination of Ubc7 (the yeast ortholog of E2G2) is recognized by the proteasome and may serve as a degradation signal in an auto-regulation feedback loop (17) . Since ubiquitin harbors seven lysine residues (K6, K11, K27, K29, K33, K48, K63), in principle, chains of polyubiquitin can be formed via a bond between the C-terminal glycine of one ubiquitin molecule and an amine of any of the seven lysine residues of another ubiquitin. Accordingly, seven different topologies of polyubiquitin can be generated (excluding mixed topologies) (18) . Even though most ubiquitin dependent proteasomal degradations were found to be mediated by K48 polyubiquitin chains, certain evidence suggests that K6 (19) , K11 (19, 20) and K29 (21) may also target substrates for proteasomal degradation. Polyubiquitinations through non-K48 lysines exist in vivo and play a role in a range of cellular processes (22, 23) . For example, chains polymerized via K63 were shown to participate in the DNA damage response (24, 25) . K63 linkages were also shown to be required for endolysosomal degradation of class I MHC molecules, NFkB activation, and for targeting EGFR to the lysosome (26) (27) (28) . K11 conjugates were shown to be catalyzed by the APC E3 complex and E2C (29) , while K6 and K11 chain-topologies were found on the aggregated PHF-Tau in Alzheimer's disease (30) . K6 was also implicated in DNA repair while K29 may function in proteasome degradation (21, 22) .
To systematically study the mode of action of the E2 family of enzymes, we cloned, expressed and purified all of the annotated human E2 enzymes. As a control, we expressed the well documented yeast Ubc13/UEV1a and the Ubc5 family members (Ubc5A, Ubc5B and Ubc5C).
Initially, we monitored the ability of the various purified E2 enzymes to function in vitro in autoubiquitination reactions and then corroborated our findings by characterizing substrate ubiquitination by these E2s. We determined by mass spectrometry the lysine specificity in ubiquitin-conjugates generated by the different E2 and the site of ubiquitination. In conjunction, we preformed polyubiquitination reactions in the presence of a gallery of single lysine or arginine ubiquitin derivatives (20) . This rigorous analysis gave rise to the realization that the E2 enzymes may have a role in selecting the target's lysine. . EXPERIMENTAL PROCEDURES Purification of the human E2 ubiquitin conjugating enzymes The complete CDS of the annotated human E2 ubiquitin conjugating enzymes were subcloned from a human cDNA library by PCR. The amplified genes were inserted into the bacterial expression vector pET22 in frame to a C-terminal 6XHis tag. The desired plasmid was transformed into E.Coli (BL-21 DE3). The bacteria were grown overnight in 50 ml LB medium complemented with 100 µg ampicillin/ml. This starter served to inoculate two liters of culture that were grown until the optical density of 0.6 at 600 nm was reached. Protein expression was induced by IPTG addition (0.5 mM final concentration) and further growth for 3 hours. The bacteria were harvested resuspended in buffer A (20 mM Hepes, pH7.5, 20 mM immidazole), and lysed by sonication. The lysates were cleared by centrifugation (14,000 rpm, 30 minutes, 4 o C) and the supernatant was loaded on a homemade Ni-NTA column. Following absorption, the column was washed with buffer B (20 mM Hepes, pH 7.5, 1M NaCl, 1% Tween 20) and buffer A, the bound proteins were eluted with 0.5 M immidazole in PBS. The pure protein was dialyzed overnight against PBS and stored at -80 o C. Cloning and purification of single lysine and single arginine derivatives of ubiquitin Plasmid constriction The human wild type ubiquitin was cloned into pET22 and used as a template for site directed mutagenesis. Initially, we substituted all seven lysine residues of ubiquitin by arginines (0K ubiquitin). We then added back each of the seven lysines to its original position, one at a time, (denoted as KX where the X stands for the position of the single lysine added) (20) . Single arginine ubiquitin mutants were generated by substituting each lysine of the wild type ubiquitin (one at a time) to arginine using site directed mutagenesis (denoted as RX where the X stands for the position of the single arginine substituted). Purification of wild type and single arginine ubiquitin derivatives All single arginine ubiquitin mutants and wild type ubiquitin were transformed into E. Coli BL-21 DE3, grown and induced as described in the previous section. The bacteria were harvested by centrifugation, resuspended in 20 mM Hepes (pH 7.5) and lysed by sonication. Following centrifugation (16000 g), the supernatant was dialyzed overnight against 100 mM acetic acid calibrated by NaOH to pH 5. The lysate was then cleared by centrifugation (14,000 rpm, 30 minutes, 4 o C) and the supernatant was fractionated on Mono-S anion exchange column using HPLC. The ubiquitin was eluted by a salt gradient at about 350 mM NaCl. The relevant fractions were collected and concentrated on a nitrogen based ultrafiltration device using a 1 kDa cutoff membrane. The sample was then fractionated on an S-30 gel filtration column using 50 mM Hepes, pH 7.5 and 100 mM NaCl. The relevant fractions were collected, concentrated again by a 1kDa cutoff ultrafiltration device and stored at -80 o C.
Purification of single lysine mutants
Following induction the bacteria were harvested by centrifugation and resuspended in 6 M Guanidine-HCl in 20 mM Hepes, pH7.5, and lysed by sonication. The lysate was then cleared by centrifugation (14,000 rpm, 30 minutes, 4 o C) and the supernatant was passed through 30 kDa cutoff nitrogen based ultrafiltration device. The flowthrough was further concentrated using a 1 kDa cutoff and fractionated on an S-30 gel filtration column using HPLC as described above. The relevant fractions were collected, concentrated by a 1 kDa cutoff nitrogen based ultrafiltration device and store at -80 o C.
In vitro polyubiquitination reactions
In vitro polyubiquitination reactions contained 30nM of the human recombinant E1 (Boston Biochem), 0.5µM of the indicated E2 enzyme, and 10µM of wild type ubiquitin or one of the desired purified single lysine/ arginine mutants. The polymerization reactions were carried out in 50µl buffer C (30 mM Hepes, pH 7.5, 5 mM MgCl2, 2 mM ATP, 0.2 mM DTT, 10 mM sodium citrate, 10 mM creatine phosphate and 0.2 µg/ml creatine kinase; final concentrations in the reactions mixtures). The reaction was prepared on ice and incubated for 4 hours at 37 o C. For analysis, the samples were boiled with sample buffer, separated on an SDS-PAGE, transferred to a PVDF membrane and western blotted with the indicated antibody. Distinguishing between lysine and cysteine selfubiquitination the E2 enzymes In vitro polyubiquitination reactions were performed as described above. Ni-NTA beads were pre-washes in buffer D (20 mM hepes, pH 7.5) and then added to the reaction mixture. Absorption to the beads was performed at 4 o C on a rotating platform (950 rpm) for 2 hours. The beads were sedimented by centrifugation, washed twice with buffer D, twice with buffer B, and two additional times with Buffer D. One half of the beads were boiled in sample buffer containing 100 mM DTT and the other half in sample buffer without DTT. Corresponding pairs of reduced and non-reduced samples were separated on SDS-PAGE and analyzed by anti-His and anti-ubiquitin antibodies.
Polyubiquitination of His-RFP bound derivatives
His-RFP derivatives (RFP-Ub, RFP and RFP-Ub-GW) were conjugated to Ni-NTA beads to saturation. The RFP-conjugated beads were washed twice with buffer D, twice with buffer B, and two more times with buffer D. 15µl of saturated beads were used for each polyubiquitination reaction in the presence of wild type ubiquitin as described above. The reactions were incubated for 4 hours at 37 o C on a rotating platform (950 rpm). RFP derivatives were separated from the bulk solution by centrifugation and washed twice with buffer D, twice with buffer B, and two times with buffer D. The beads were resuspended and boiled in sample buffer, separated on SDS-PAGE and analyzed by western blot with anti-RFP (MBL). TEV protease digestion of polyubiquitinated RFP-Ub Polyubiquitinated RFP-Ub bound to Ni-NTA beads (prepared as described above) were washed twice with TEV reaction buffer (50 mM Tris, pH 8, 1 mM DTT). Each reaction was supplemented with 15 µg TEV-protease and incubated at 4 o C for 24 hours. The beads were then separated from the reaction mixture by centrifugation, washed twice with 50 mM Tris, pH 8, boiled in sample buffer, 
Mass Spectrometry detection of ubiquitinated lysine residues
Large scale polyubiquitination reactions were separated on SDS-PAGE gel and stained with Imperial Blue (Pierce). Certain regions and discrete bands were excised from the gel, reduced (10 mM DTT), modified with 40 mM iodoacetamide and treated with trypsin or chymotrypsin (modified trypsin, Promega) at a 1:100 enzyme-to-substrate ratio. The resulting tryptic peptides were resolved by reverse-phase chromatography on 0.075 X 200-mm fused silica capillaries (J&W) packed with Reprosil reversed phase material (Dr Maisch GmbH, Germany). The peptides were eluted with linear (over 50 minutes) gradients of 5% to 45% acetonitrile-0.1% formic acid the tightly bound peptides were collected by a 15-minute wash by 95% acetonitrile, 0.1% formic acid in water. All through the run the flow rate was 0.25 µl/min. Mass spectrometry was performed by an ion-trap mass spectrometer (Orbitrap, Thermo) in a positive mode using repetitively full MS scan followed by collision induces dissociation (CID) of the 7 most dominant ion selected from the first MS scan. The mass spectrometry data was analyzed using the Sequest 3.31 software (J. Eng and J.Yates, University of Washington and Finnigan, San Jose) searching against the human part of the NR-NCBI database. Identification threshold of Xcorr value of above 2.0 for doubly charged peptides, and 2.5 for triply charged peptides, were employed. In addition, the identification of the ubiquitinated peptides was assessed visually by a trained operator. Ubiquitination was identified as a mass addition of 114Da to the relevant peptide (the GG from the Cterminus of ubiquitin attached to a lysine residue). E2 Dimerization assay About 0.05 µg (~50nM) of each of the purified E2 enzymes was incubated in 50µl of 20mM Hepes pH7.5. complimanted with 0.05µM final concentration of cross linker DTSSP (Pierce) was added to each sample. The samples were left shaking for 1 hour at room temperature. The reactions were quenched with 20mM Tris pH 7.5. The samples were then divided to two portions. Half of the reaction mixture was boiled with sample buffer containing 100mM DTT, while the second portion was added boiled in sample buffer without reducing agent. The samples pairs were separated on SDS-PAGE gel and analyzed by western blot using α-His antibody.
Far Western
Following cross-linking (see above) the dimerization reactions were boiled in sample buffer without DTT, separated on SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was then washed with ubiquitination buffer (Buffer C) for three times. E1 (250nM) and wild type ubiquitin (100µM) were added and the membanes were incubated for an additional hour at room temperature. The reactions were stopped by extensive washing with TBST, blocked with 5% milk and analyzed by western blot with anti ubiquitin. RESULTS E2 enzymes auto-ubiquitinate both their active site cysteine and lysine residues The human E2 family of enzymes were cloned and expressed in bacteria genetically fused to a 6XHis tag to aid in purification and detection ( Figure  S1A , Table S1 ). Initially, we optimized an in vitro self-ubiquitination reaction for E2 enzymes that possess an active site cysteine within the Ubc domain (the conserved catalytic motif of the E2 family). All E2 enzymes tested catalyzed polyubiquitin chain formation in the absence of an E3 and a substrate ( Figure S1B ). As expected, E2M, E2F and E2I which are E2 enzymes of ubiquitin-like proteins, did not form ubiquitin conjugates in vitro. We excluded the possibility that polyubiquitin was assembled on the E2 enzymes by an E2 independent action of the E1 enzyme in control reactions using the naturally occurring active site cysteine mutants E2s (e.g. FTS, UEV1/2). Next, we determined if free polyubiquitin chains accumulated in the reaction mixture or whether the detected ubiquitin conjugates were linked to the E2 enzymes themselves, either to the active site cysteine, or to lysine residues. For this purpose, following the polyubiquitination reaction, the E2 enzymes were captured onto Ni-NTA beads. Western blot analysis of the unbound material by an anti-ubiquitin antibody indicated that almost all of the ubiquitin polymers were confined to the beads (data not shown). In parallel, half of the washed beads were boiled in sample buffer containing DTT (100 mM), while the second part was boiled in sample buffer without DTT. The boiled pairs of mixtures corresponding to all of the examined E2 enzymes were then separated on SDS-PAGE, and the E2 species were detected by anti-His tag antibody. Polyubiquitin moiety, linked to the active site cysteine, should detach from the E2 upon boiling in the DTT containing sample buffer. In contrast, polyubiquitin linked to a lysine side chain should be unaffected by the DTT. In the case of E2A, Ubc5A, Ubc5B, Ubc5C, E2D1, E2D2, E2D3, E2E1, E2G1, E2G2, E2J2, E2L3, E2R1 and E2R2 (group 1), the DTT in the sample buffer liberated most of the polyubiquitin from these E2 enzymes and the high molecular weight species of E2s were lost (Figure 1, panel A) . The size distribution profiles of E2B, E2C, E2D4, E2E2, E2E3, E2H, E2L6, E2N/ E2V1, E2N/E2V2, E2Q2, E2S, E2T, E2W, E2-25K and the yeast Ubc13/UEV1a (group 2) were unaffected or partially affected by the presence of DTT, suggesting that polyubiquitin moieties in these reactions were mostly bound to lysine residues of the E2 enzymes or both to the active site cysteine and lysine residues (Figure 1 panel B) . These findings were supported by mass spectrometry analyses, which detected ubiquitin-modified lysine residues on most DTT insensitive ubiquitinated E2s and did not identify such residues when the DTT sensitive ubiquitinated E2s were analyzed (see below, Table 1 ). An example of a complete gallery of the peptides detected by mass spectrometry following a ubiquitination reaction is presented in Table S2 . A thiol ester linked ubiquitin to the E2 active-site is an intermediate in any polyubiquitination reactions. Accordingly, one possible explanation for non active-site ubiquitination seen in group 2 ( Figure 1B ) might result from a subsequently, slower, non specific transfer of the polyubiquitin from the active site cystein to a neighboring lysine on the E2. If true, such a non specific transfer is anticipated to be significantly enhanced by the long incubation time used here (four hours). To exclude this possibility we performed representative ubiquitinations reactions (group 2) with a shorter time scale (20 min). Although following shorter incubation periods, lower amounts of ubiquitination species were detected, the type and character of the ubiquitination did not change ( Figure S2 ). Thus, group 2 capacity to promote auto-ubiquitination on lysine residues appears to be a genuine function of these E2s, at least in vitro.
E2 enzymes catalyze polyubiquitin formation through preferred lysine residues
Global in vivo analysis of the specific lysine residues engaged in polyubiquitination indicated that all seven lysine residues of ubiquitin participate in ubiquitin polymerization (23, 31) .However, it is unclear how the selection of a specific lysine residue transpires in a given polyubiquitination reaction. To explore whether the E2 directs the type of polyubiquitination, we analyzed the conjugates that were generated by each E2 enzyme by mass spectrometry. Briefly, following in vitro scaled-up selfpolyubiquitination reactions in the presence of wild type ubiquitin, the reaction mixtures were separated on SDS-PAGE and the gel was stained (Imperial, Pierce). Regions or specific bands were subjected to mass spectrometry analysis ( Figure  S3 , Table 1 ). To complement our mass spectrometry analysis, we also performed similar polyubiquitination reactions in the presence of a panel of single lysine and single arginine variants of ubiquitin (20) . Western blot analysis of these reactions with an anti-ubiquitin antibody, indicated that all seven lysine residues of ubiquitin could serve in ubiquitin-ubiquitin conjugation ( Table 1) (Table 1) . However, our single lysine/arginine assays also suggest that E2S can utilize the other single lysine derivatives of ubiquitin to some extent, except K48 ubiquitin ( Figure 2B left  panel) . Accordingly, in the complementary single arginine experiments, all single arginine derivatives of ubiquitin supported polyubiquitination ( Figure 2B right panel) . In agreement with the mass spectrometry analysis, most of the E2 enzymes showed preference to a specific lysine (or a small subset of lysine residues) when catalyzing polyubiquitination. Interestingly, both methods detected a clear preference toward K48, K11 and K63.
A notable observation is the frequent involvement of K11 of ubiquitin in polyubiquitination. This phenomenon was observed both in the mass spectrometry analyses, as well as in the single lysine/arginine experiments (Table 1 and figure S5 ). Although the specific role of K11 polyubiquitin topology is unclear, it was found to be conjugated to the accumulated PHFTau in Alzheimer's disease (30) and was shown to be recognized by the 26S proteasome (20) . Moreover, recently K11 linkages were also proposed to have a function in the ERAD pathway (31) . Indeed, when whole cell lysate was analyzed by mass spectrometry for the abundance of the different lysines involved in polyubiquitin, K11 conjugates appeared as abundant as K48 conjugates, both more prevalent than the other topologies (23) . Tethering of a substrate to an E2 promotes its polyubiquitination As demonstrated, all purified human E2 enzymes catalyzed in vitro polyubiquitin assembly in the absence of an E3 ubiquitin ligase. However, most of these ubiquitin conjugates were in the form of auto-ubiquitination of the E2 enzymes themselves (Figure 1 ). We were unable to catalyze the transfer of ubiquitin to a model substrate (e.g. mutated form of TCRα, -Casein, BSA, and RFP) by our purified E2 enzymes in the absence of an E3 ligase (data not shown). We therefore hypothesized that in the absence of a substrate-specific E3 enzyme, the ubiquitin-bound E2 does not form a complex with the substrate and, thus, the activated ubiquitin cannot be acquired efficiently by the substrate, but rather it is transferred from one E2 monomer to the other, promoting self ubiquitination. Based on this proposed mode of action (16) and to explore this possibility further and characterize the nature of the functional link between an E2 enzyme and a substrate, we established a model system in which a given substrate could be directly linked to any E2. We genetically engineered a derivative of the Red Fluorescence Protein (RFP) with a 6XHis tag at its N-terminus and the human wild type ubiquitin at its C-terminus (His-RFP-Ubiquitin, abbreviated RFP-Ub). A TEV recognition site was inserted between the RFP and the ubiquitin domain ( Figure S6 ). We hypothesized that the ubiquitin would recruit one E2 molecule by binding to its active-site cysteine through the action of an E1 enzyme (in analogy to native ubiquitin). An additional E2 monomer would then catalyze the polyubiquitination of the RFPubiquitin fusion on either the ubiquitin or the RFP portion of the RFP-Ub in a similar manner to the assembly of polyubiquitin on E2G2 (16) . To monitor the level of polyubiquitination on the substrate, agarose Ni-NTA beads were saturated with RFP-Ub and used for in vitro polyubiquitination reactions on beads, in the presence of E1, ubiquitin and the different E2 enzymes. Once the reactions were completed, the polyubiquitinated RFP-Ub bound beads were separated from the bulk solution and thoroughly washed. The beads were then boiled with sample buffer and separated on SDS-PAGE. All the E2 enzymes, with the exception of E2L3, efficiently polyubiquitinated RFP-Ub (see Figure 3 , left panel for representative reactions & Figure S7A for the complete data). Next, we scaled up the RFP-Ub polyubiquitination reactions, separated the reaction products by SDS-PAGE and stained the gel (see Figure 3 , right panel for representative reactions & Figure S7B for the complete data). Regions of polyubiquitinated species, as well as specific bands, were excised from the gel and analyzed by mass spectrometry to determine which lysine residues on the RFP-Ub fusion were conjugated to ubiquitin. Only a small subset of the E2 enzymes (E2B, E2C, Ubc5B, Ubc5C, E2D4 and E2T) directly ubiquitinated the RFP portion of the chimera (Table 1 and Figure S8 ). The rest of the E2 enzymes could only link ubiquitin to the ubiquitin portion of the RFP-Ub fusion. Both types of ubiquitinations were highly specific in the selection of lysine residues modified by ubiquitin (Table 1 ) and in complete agreement with the lysine preference determined in the E2 self-ubiquitination mass spectrometry analyses. To estimate the ratio of the ubiquitination linked to the ubiquitin portion of the RFP-Ub relative to the direct ubiquitination of the RFP domain, we separated the ubiquitin and the RFP portions using the TEV protease. Briefly, following polyubiquitination reaction, the RFP-Ub beads were spun down and washed extensively. Following incubation of half the beads with TEV protease, pairs of mixtures (with and without TEV treatment) corresponding to all of the examined E2 enzymes were separated on SDS-PAGE and analyzed by anti RFP antibodies (Figure 4) . Our results indicate that even in ubiquitination reactions where the E2s ubiquitinate the RFP itself, almost all of the ubiquitinaiton occurred on the ubiquitin domain and not the RFP. Accordingly, after TEV digestion, most of the ubiquitinations were removed from the RFP (Figure 4 & S9) . Although RFP has 23 lysine residues (2 buried and 21 exposed), only 5 of these were ubiquitinated in our in vitro assay using the various E2s ( Figure  S8 ). The ubiquitinated lysine residues on the RFP were not necessarily the closest ones to the ubiquitin domain of the molecule, but were positioned in all cases on flexible loops at the edges of secondary structures. It is noteworthy that exactly the same characteristics of ubiquitination sites were evaluated in vivo by Catic et. al. (35) . Again, ubiquitnation sites were found to be located on flexible loops and on the edges of α helix structures.
The integrity of the ubiquitin portion of RFPubiquitin is essential for ubiquitination
To verify the role of the ubiquitin portion of the RFP-Ub fusion in the polyubiquitination reaction, we generated two more derivatives of RFP: a His-RFP that does not have a ubiquitin domain (RFP) and a RFP-Ub in which the C-terminal glycine was substituted by tryptophan (RFP-Ub-GW). These derivatives were conjugated to Ni-NTA beads and served in polyubiquitination reactions (as described for the RFP-Ub). Following polyubiquitination, the beads were thoroughly washed, boiled with sample buffer, separated on SDS-PAGE and analyzed by western blot with both anti-RFP and anti-ubiquitin antibodies. As seen in Figure S11A , when RFP beads were used as a substrate high molecular weight species of RFP were hardly detected. Thus, the ubiquitin portion of the fusion was essential for polyubiquitination of the RFP. If our model is correct and the RFP-Ub fusion is anchored to the E2 enzymes via their active site cysteine, then the presence of a C-terminal glycine in the ubiquitin should be crucial for efficient polyubiquitination of the RFP. To evaluate this possibility, we used the second derivative (RFP-Ub-GW). As shown in Figure S11B , Ni-NTA beads pre-conjugated to RFP-Ub-GW did not serve as substrates for polyubiquitination by the different E2 enzymes, as evident from the lack of high molecular weight species of RFP. Taken together, these results suggest that tethering of the RFP to specific E2 via the active site cysteine is sufficient to promote efficient polyubiquitination of the bound substrate. E2 enzymes spontaneously dimerize in vitro As mentioned above, one way to juxtapose a pair of ubiquitin molecules for ubiquitin-ubiquitin formation might be through dimerization of E2 enzymes (36) (37) (38) . As our experiments with RFPUb possibly support the notion that the E2 enzymes functionally act as dimers, we set to examine whether E2 enzymes form spontaneous dimers, by conducting an in vitro cross linking experiment. Similar amounts of the different purified E2 enzymes (~5nM) were incubated in 20nM Hepes buffer (pH=7.5) in the presence of 10µM DTSSP (Pierce), a primary amines reactive homobifunctional cross-linker in which two Nhydroxysuccinimide ester groups are linked through a disulphide bridge. As such, any complex, cross-linked by DTSSP, should dissociate upon exposure to a reducing agent such as DTT. Following one hour incubation on a rotating platform, the cross linker was quenched with 200mM Tris and the reaction mixture was divided in two. To one portion we added sample buffer with DTT, while the other half of the sample was boiled in sample buffer without reducing agent. All the E2 reaction pairs were separated on SDS-PAGE and analyzed by western blot with anti-His antibodies. As seen in Figures 5A & S10 almost all E2 enzymes spontaneously formed dimers in solution (in the absence of a charged ubiquitin) and this dimerization was reproducibly captured by cross-linking. Ubc5C, UBE2E1, UBE2E2 and UBE2E3 did not consistently form dimers under these conditions. Possibly, these E2 enzymes form a more labile dimer. Next, we set to examine which form of the E2 (monomeric or dimeric) could be charged with ubiquitin by the action of an E1. For this end we performed a far western experiment following cross linking of E2C, E2T and E2-25K with the DTSSP. Briefly, the dimeric and monomeric forms of the cross-linked enzymes were separated on an SDS-PAGE and blotted onto a nitrocellulose membrane. The membrane was washed with polyubiquitination buffer (buffer C) and immersed in the minimal volume possible of the same buffer in the presence of E1 and wild type ubiquitin. The reaction was incubated with slow shaking for four hours and terminated by extensive washing with TBST. The membrane was then blocked with 5% milk and blotted with anti ubiquitin. As seen in Figure 5B , for all three enzymes (E2C, E2T and E2-25K), both the monomeric and dimeric forms were detected with the anti-ubiquitin, illustrating that both monomeric and dimeric forms could be charged with ubiquitin by the action of the E1. Uniform versus mixed topologies in polyubiquitination The fact that certain E2 enzymes may polymerize ubiquitin through more than one lysine residue in ubiquitin raises the possibility that a given E2 enzyme may promote polyubiquitination in three possible chain topologies: homogenous, i.e. all the ubiquitin molecules in a given polyubiquitin chain are linked through the same lysine; mixed, where different ubiquitin molecules in the same polyubiquitin are linked through different lysine residues (27, 39) ; or branched (heterogeneous), i.e. some of the ubiquitin molecules in the polyubiquitin are bound to other ubiquitins on multiple lysine residues (40) . In addition, more complex configurations of various mixtures of these topologies are also theoretically possible. In an attempt to address these possibilities, we resolved on SDS-PAGE the reaction products of large scale polyubiquitination reaction of all active E2 enzymes. The gel was stained and distinct bands (rather than regions) were analyzed by mass spectrometry. Interestingly, specific polyubiquitin species (bands) generated by E2 enzymes, which showed promiscuous specificity, contained uniform polyubiquitin topologies, conjugated through only one of the lysines. For example, analysis of a specific band (E2T lower band, Figure S3A , band #15) detected only K11 conjugates from a range of in vitro polyubiquitin conjugates generated by E2T (K11, K27, K48 and K63). In addition, although our mass-spectrometry analysis detected fragments of ubiquitin with more than one lysine, we did not detect ubiquitinderived peptides containing two conjugated lysine residues. In contrast, we did detect multiple peptides of E2S, in which two consecutive lysine residues were conjugated to ubiquitin (Table S2B ). This finding suggests that in vitro E2 rarely (if at all) catalyze the formation of branched polyubiquitin chains.
DISCUSSION

E2 enzymes have a role in determining the lysine preference in ubiquitination
Our results suggest that most E2 enzymes can only generate polyubiquitin chains through a specific lysine or a limited subset of lysine residues of ubiquitin ( Table 1 ). The lysine preference was assessed using three independent experimental approaches: mass spectrometry analyses of both E2 enzymes following an auto-ubiquitination reaction and of ubiquitin conjugates on a substrate (RFP-Ub), as well as biochemical analysis of ubiquitination with single lysine/arginine ubiquitin mutants. Combined, these results demonstrate that the E2s themselves posses an inherent preference for specific lysine residues when promoting polyubiquitin chain assembly. Furthermore, comparing the lysine specificity of the E2 enzymes examined here to several studies where the lysine specificity of an E2 was determined in conjunction with an E3 enzyme, clearly shows that the ability of a given E2 enzyme to polymerize ubiquitin through a specific lysine is not altered by the E3. This notion is illustrated in the following examples: BRCA/BARD, an E3 ligase was shown to act with E2-25K and generate K48 conjugated chains, while with E2N/E2V1 (Ubc13/UEV1a) it catalyzes the formation of polyubiquitin chains conjugated through K63 (41) . Pellino1 E3 also acts with E2N/E2V1 to generate lysine K63 chains, whereas when acting with E2R (Ubc3/CDC34) it catalyzes the formation of K48 chains. When this E3 functions with the E2D family (Ubc4/5) it promotes the formation of K11 and K48 chains (42) . Polyubiquitinations through K11 were also shown to be preferentially generated when E2C (UbcH10) and E2S are recruited to the APC E3 complex (34) . In our in vitro analysis, E2-25K and E2R (CDC34) generate K48 chains while Ubc13/UEV1a could conjugate ubiquitin only trough K63. The E2D family, utilizes both K11 as well as K48 whereas E2C (UbcH10) preferentially used K11 and K48 when catalyzing polyubiquitin chains formation. Thus, our in vitro results are in a perfect agreement with the previously published data where the E2 enzymes were studied in the context of an E3 in vitro and in vivo.
Even when multiple lysine preferences were found for an examined E2 (depending on the specific E3 it functions with) these preferences coincide with the multiple capacities to conjugate ubiquitin that were assigned to this E2 in our in vitro approach. For example, E2D (UbcH5) catalyzes K48 chain topologies when acting with the E3 E6-AP and K63 conjugates with Nedd4, both are HECT domain E3 ligases (40) . Likewise, the yeast homolog of Nedd4, RSP5, catalyzes K63 chains on various substrates when acting with Ubc4 and Ubc5 (E2D) (43, 44) . In line with these reports, we show that in vitro E2D can utilize both K48 and K63 in polyubiquitination. A broader range of lysine specificity was detected when the Rad6 (E2A/B) was used in polyubiquitination with various E3s (Bre1, Ubr1, Rad18) (20, 34, 45) each selecting different lysine specificity from the potential conjugation abilities of Rad6 (K11 and K48). In aggregate, the clear overlap in the lysine preferences demonstrated by a given E2, independent of the presence or absence of an E3 enzyme is a strong indicative of the central role of the E2 enzymes in the determination of the lysine preference in ubiquitination. We conclude that while the role of the E3 is to select the E2 enzyme and perhaps its mode of action (i.e. select specific lysine preference when multiple lysine residues of ubiquitin could be used by the E2), the latter determines the type of ubiquitin chains formed. Additional support for the direct role of E2 enzymes in dictating the lysine preference of ubiquitin conjugates comes from analysis of structural motives in E2 enzymes. E2-25K (32), E2D3 (UbcH5C) (46) and UBC13/UEV1a (E2N/E2V1) (47, 48) . They were all shown to contain a region which interacts non-covalently with the attacking ubiquitin in such a manner that the this ubiquitin molecule is poised by this interaction to form lysine specific linkage with the active site bound ubiquitin (49, 50) . In support of this notion, we detected that E2T catalyzed ubiquitin polymerization through K27 of ubiquitin (Table 1 and Figure S3 ). AsK27 appears buried within the ubiquitin (1UBQ.pdb), the conformation of the attacking ubiquitin is most likely affected by the interaction with E2T, such that its K27 would become poised to attack the thioester bond of the E2T active site bound ubiquitin and acquire the activated ubiquitin.
A major role for the E2 enzymes in determining the lysine preference in polyubiquitination is also compatible with the study of Li et.al., (16) who suggested that the polyubiquitin chain is first assembled on the E2 by a 'ping-pong' action of a pair of E2 molecules. In this model only once a polyubiquitin chain is matured, it is transferred as a module to the substrate. Here, the ubiquitin chain topology must be determined by the E2, as the E3 operates only following assembly of the polyubiquitin tree. It is noteworthy that in our self-ubiquitination assay a significant number of E2 enzymes accumulated polyubiquitin chains on their active site cysteine in the absence of an E3 ( Figure 1A) . The E2s mode of action One simple model to account for the initial assembly of polyubiquitin chain on an E2 enzyme prior to its 'en block' acquiring by the target (as was demonstrated by Li et.al., (16) ) is through a 'ping-pong' action of a pair of E2 molecules. In terms of processivity, there is a clear advantage for E2 enzymes to act as dimers, since at least one of the E2 monomers may remain associated with the substrate, while maintaining continuous additions of ubiquitin monomers an intramolecular reaction. This can be attributed to the fact that the E1 and the E3 binding sites on the E2 enzyme overlap and their binding to the E2 is mutually exclusive (51) . Thus, sequential addition of ubiquitin will probably require multiple cycles of E2-E3 binding and release. The presence of a stable E2 dimer in the E2-E3 complex might circumvent the need for complete dissociation of the E3 from the E2 providing the E1 and E3 bind to different E2 monomers in the dimer. Moreover, this model of "ping pong" action of the E2 enzymes in a dimer may conserve certain constrains, which may be important in terms of lysine specificity, length of the polyubiquitin and other attributes of the polyubiquitin moiety, which might depend on the specific setup (i.e. components and conditions of the reaction). The results of our in vitro E2 dimerization analysis suggest that all E2s can spontaneously form dimers in solution independently of the presence of activated ubiqutin. Additionally, both the dimer and monomer forms can be charged with ubiquitin by the action of an E1. Although not conclusive these findings support the raising notion that E2s act as dimers when catalyzing polyubiquitination.
It is noteworthy that both in vitro and in vivo analyses performed in the past have recognized an ability of certain E2 enzymes to form dimers, particularly if the E2 is charged with ubiquitin. The homodimerization of the yeast E2, Cdc34 (E2R), is induced by ubiquitin thioester formation and is necessary for its function (52) . Heterodimer formation between the yeast E2s Ubc6 (E2J) and Ubc7 (E2G) was suggested by yeast two-hybrid analysis (37) and implicated in ERAD (53) . Yet, the clearest demonstration of functional dimer in ubiquitin chain assembly was revealed in the structural and functional analysis of the heterodimer formed between Ubc13 (E2N) who only acts with the inactive E2 UEV (Ubiquitin-E2 Variant) proteins, and catalyzes lysine 63 ubiquitin conjugates (33) . It is relatively simple to envision a possible model in which the E2 selects the target lysine in ubiquitin conjugation when a RING E3 is engaged. However, it is probably less intuitive when the E2 is acting with a HECT domain E3. In this scenario, the target lysine on the substrate is determined by the E3 itself (9, 39, 54) . Unless the polyubiquitin is initially assembled on the active site cysteine of the HECT E3 by the action of the conjugated E2, and only then is acquired by a lysine residue on the target (55) . In this respect, the set of E2s known to operate with HECT E3s includes the E2D family, E2L3 (UbcH7) E2G (Ubc7) (17, 39, (56) (57) (58) (59) . Interestingly, all of these E2s were found to assemble polyubiquitin on their own active site cysteine in our assay (Figure 1) . This raises the possibility that the lysine preference in a given polyubiquitination reaction is affected by the specific E2 enzyme engaged even when a HECT E3 is coordinating the polyubiquitination reaction. Yet, recent study suggested that the HECT E3s E6AP and RSP5 generate lysine specific chains regardless of the interacting E2 (60) . CONCLUSIONS Polyubiquitination occurs through all seven lysines of ubiquitin. Here we provide a mechanistic link between specific topologies and the activity of specific E2 enzymes. We suggest that the lysine specificity of the E2 enzymes determined here, in vitro, may infer to the in vivo capabilities of these E2s. Our data suggest that polyubiquitination through K11 of ubiquitin is as common as those of K48 and is catalyzed by many of the E2s. Similarly, while not as abundant, polyubiquitination through K63 is also frequent.
We propose a mechanism by which the E3 enzyme governs the identity of the recruited E2 enzyme, the substrate specificity, the mode of action (mono or polyubiquitination) and, perhaps, the general region in the substrate to be ubiquitinated. The E2, in turn, catalyzes the desired type of ubiquitination on a specific lysine residue in that region. Figure 1 : Recombinant human E2 enzymes catalyze self-ubiquitination in vitro. Auto-ubiquitination of E2s absorbed to Ni-NTA beads. Following ubiquitination the washed beads were boiled in sample buffer with and without DTT. Pairs of boiled beads corresponding to all E2 enzymes were separated by SDS-PAGE and analyzed for co-migration of the ubiquitin and the E2 enzymes by anti-His antibody. (A) E2 enzymes in which the self-ubiquitination was mainly limited to the active site cysteine. (B) E2 enzymes that auto-ubiquitinated mainly on a lysine residue. The E2s categorization was also supported by mass spectrometry detection of ubiquitin modified lysine residues only of the E2s belonging to group 2. Polyubiquitination reactions of RFP-Ub beads were conducted as described in Figure 3 . Each reaction was divided, and one half was subjected to TEV protease digestion. The TEV-treated and untreated portions were separated side by side on SDS-PAGE and analyzed by western blot analysis with anti-RFP antibody. Representative reactions of E2s that did not directly ubiquitinate the RFP portion (E2A, E2E2 left panel) and E2s that directly add ubiquitin to the RFP portion (E2C, Ubc5C, right panel). Similar analysis of all other E2s is depicted in figure S9 . Figure S10. (B) . Both the monomeric and dimeric forms of the E2 can acquired ubiquitin. Following cross-linking E2-25K, E2T and E2C were separated to dimeric and monomeric forms on non-reducing SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was incubated with E1 and wild type ubiquitin in standard ubiquitination conditions. Charging of the monomeric and dimeric forms was determined by western blot analysis with anti ubiquitin. (Table S2) Origin of analyzed MS sample ( Figure  S3 
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